Value Bridge — THE JOHNS HOPKINS HOSPITAL
Current $-123M → Target $-69M (+$54.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-123.3M
Current EBITDA
$-68.8M
Target EBITDA
+$54.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$12.3M
Payer Mix Optimization
$29.6M
Cost to Collect Reduction
$9.9M
Clean Claim Improvement
$7.4M
Volume & Rate Growth
$49.3M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-123M to $-69M. The highest-impact lever is Volume & Rate Growth at $19.7M probability-weighted.
IC talking point: "We see $54M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $599M in equity value creation."